10X Genomics (TXG) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US88025U1097

10X Genomics, Inc., listed on NASDAQ as TXG, is a leading life science technology company. The company focuses on creating and distributing cutting-edge instruments, consumables, and software designed for analyzing biological systems worldwide. Operating in regions such as North America, Europe, the Middle East, Africa, China, and the Asia Pacific, 10X Genomics offers a wide range of innovative solutions for researchers and scientists.

10X Genomics delivers advanced products like chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables essential for biological analysis. One of its flagship offerings is the single-cell solutions that are compatible with chromium instruments. These solutions include single-cell gene expression analysis, single-cell immune profiling, single-cell Assay for Transposase Accessible Chromatin (ATAC), and single-cell multiome ATAC + gene expression technology, enabling precise measurement of gene activity and epigenetic programming in thousands of cells in a single experiment.

Moreover, 10X Genomics also provides the visium spatial gene expression solution, allowing researchers to assess spatial gene expression patterns within tissue samples. When combined with immunofluorescence, this solution enables gene expression and protein co-detection, paving the way for comprehensive biological analyses.

Catering to a diverse clientele that includes academic, government, biopharmaceutical, biotechnology, and other institutions, 10X Genomics has established itself as a trusted partner in the scientific community. Originally known as 10X Technologies, Inc., the company rebranded as 10X Genomics, Inc. in November 2014. Founded in 2012, the company's headquarters are located in Pleasanton, California. For more information, visit their official website at https://www.10xgenomics.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for 10X Genomics (TXG) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for 10X Genomics (TXG) - Stock Price & Dividends

TXG Stock Overview

Market Cap in USD 4,332m
Sector Healthcare
Industry Health Information Services
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2019-09-12

TXG Stock Ratings

Growth 5y -3.17
Fundamental -6.01
Dividend -
Rel. Performance vs Sector -5.06
Analysts 4.20/5
Fair Price Momentum 27.33 USD
Fair Price DCF -

TXG Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

TXG Growth Ratios

Growth 12m -38.81%
Growth Correlation 12m -44%
Growth Correlation 3m -50%
CAGR 5y -9.77%
Sharpe Ratio 12m -0.92
Alpha vs SP500 12m -74.83
Beta vs SP500 5y weekly 1.67
ValueRay RSI 18.53
Volatility GJR Garch 1y 51.79%
Price / SMA 50 -20.32%
Price / SMA 200 -28.61%
Current Volume 1309.1k
Average Volume 20d 1276.8k

External Links for TXG Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of TXG stocks?
As of April 16, 2024, the stock is trading at USD 32.86 with a total of 1,309,105 shares traded.
Over the past week, the price has changed by -9.97%, over one month by -9.55%, over three months by -26.17% and over the past year by -39.18%.
What is the forecast for TXG stock price target?
According to ValueRays Forecast Model, TXG 10X Genomics will be worth about 31 in April 2025. The stock is currently trading at 32.86. This means that the stock has a potential downside of -5.81%.
Issuer Forecast Upside
Wallstreet Target Price 57.1 73.7%
Analysts Target Price 60.3 83.6%
ValueRay Target Price 31 -5.81%